{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:53:02Z","timestamp":1790031182679,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["AC43"],"award-info":[{"award-number":["AC43"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["AFRAVIH2016-1845"],"award-info":[{"award-number":["AFRAVIH2016-1845"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW007995"],"award-info":[{"award-number":["D43TW007995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.arcped.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T17:50:22Z","timestamp":1562953822000},"page":"254-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali"],"prefix":"10.1016","volume":"26","author":[{"given":"M.","family":"Sylla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.","family":"Maiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.T.","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.A.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"Fofana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dicko-Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Doumbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Orsega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2019.06.002_bib0095","series-title":"Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic. Geneve","author":"Unaids","year":"2018"},{"key":"10.1016\/j.arcped.2019.06.002_bib0100","series-title":"Prise en charge globale du VIH dans les pays \u00e0 ressources limit\u00e9es","author":"Expertise France","year":"2015"},{"key":"10.1016\/j.arcped.2019.06.002_bib0105","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2019.06.002_bib0110","series-title":"Politique et Protocole de prise en charge du VIH et du Sida","author":"MS\/SG\/CSLS","year":"2013"},{"key":"10.1016\/j.arcped.2019.06.002_bib0115","series-title":"Normes et protocoles de prise en charge antir\u00e9trovirale du VIH et du sida","author":"OMS\/CSLS\/HCNLS","year":"2016"},{"key":"10.1016\/j.arcped.2019.06.002_bib0120","series-title":"ESTHER\/Mali Prise en Charge des Personnes Vivant avec le VIH","year":"2013"},{"key":"10.1016\/j.arcped.2019.06.002_bib0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/INF.0000000000001575","article-title":"High rates of baseline drug resistance and virologic failure among ART Na\u00efve HIV-infected children in Mali","volume":"36","author":"Crowell","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arcped.2019.06.002_bib0130","series-title":"Enqu\u00eate d\u00e9mographique et de sant\u00e9 du Mali EDSM-V rapport pr\u00e9liminaire sur la pr\u00e9valence du VIH","first-page":"8","author":"CPS\/INSTAT","year":"2013"},{"key":"10.1016\/j.arcped.2019.06.002_bib0135","series-title":"Abbott Guide abr\u00e9g\u00e9 de pr\u00e9paration manuelle des \u00e9chantillons pour les dosages Abbott Real Time HIV\/HCV","year":"2010"},{"key":"10.1016\/j.arcped.2019.06.002_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/aid.2012.0283","article-title":"Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children","volume":"29","author":"Musiime","year":"2013","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.arcped.2019.06.002_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-6405-11-3","article-title":"Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort","volume":"11","author":"Pillay","year":"2014","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.arcped.2019.06.002_bib0150","series-title":"Resistance aux antir\u00e9troviraux chez les enfants infectes par le VIH-1, suivis au service de p\u00e9diatrie du CHU GABRIEL TOURE","author":"Fofana","year":"2010"},{"key":"10.1016\/j.arcped.2019.06.002_bib0155","series-title":"R\u00e9sistance aux antir\u00e9troviraux chez les patients infect\u00e9s par le VIH-1 et sous traitement de premi\u00e8re ligne apr\u00e8s au moins 36 mois","author":"Diawara","year":"2013"},{"key":"10.1016\/j.arcped.2019.06.002_bib0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0300","article-title":"High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines","volume":"29","author":"Kebe","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.arcped.2019.06.002_bib0165","doi-asserted-by":"crossref","first-page":"e71972","DOI":"10.1371\/journal.pone.0071972","article-title":"HIV-1 drug-resistance surveillance among treatment-experienced and -na\u00efve patients after the implementation of antiretroviral therapy in Ghana","volume":"8","author":"Nii-Trebi\u00a0NI","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.arcped.2019.06.002_bib0170","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/jac\/dks310","article-title":"Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting","volume":"67","author":"Maiga","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arcped.2019.06.002_bib0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jac\/dkp412","article-title":"Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali","volume":"65","author":"Germanaud","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arcped.2019.06.002_bib0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jac\/dkn234","article-title":"Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006","volume":"62","author":"Derache","year":"2008","journal-title":"J Antimicrob Chemother"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X19301058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X19301058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:51:49Z","timestamp":1760539909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X19301058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0929693X19301058"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2019.06.002","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS on behalf of French Society of Pediatrics.","name":"copyright","label":"Copyright"}]}}